CA1049406A - Isolation of hemagglutinin and neuraminidase from influenza virus - Google Patents

Isolation of hemagglutinin and neuraminidase from influenza virus

Info

Publication number
CA1049406A
CA1049406A CA217,790A CA217790A CA1049406A CA 1049406 A CA1049406 A CA 1049406A CA 217790 A CA217790 A CA 217790A CA 1049406 A CA1049406 A CA 1049406A
Authority
CA
Canada
Prior art keywords
chloride
bromide
virus
cationic detergent
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA217,790A
Other languages
English (en)
French (fr)
Other versions
CA217790S (en
Inventor
Helmut Bachmayer
Gerhard Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1049406A publication Critical patent/CA1049406A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
CA217,790A 1974-01-14 1975-01-13 Isolation of hemagglutinin and neuraminidase from influenza virus Expired CA1049406A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (https=) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
CA1049406A true CA1049406A (en) 1979-02-27

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
CA217,790A Expired CA1049406A (en) 1974-01-14 1975-01-13 Isolation of hemagglutinin and neuraminidase from influenza virus

Country Status (27)

Country Link
JP (2) JPS58407B2 (https=)
AT (1) AT345449B (https=)
AU (1) AU500250B2 (https=)
BE (1) BE824372A (https=)
CA (1) CA1049406A (https=)
CH (1) CH589453A5 (https=)
CS (1) CS191254B2 (https=)
DD (1) DD116239A5 (https=)
DE (1) DE2500785B2 (https=)
DK (1) DK140003B (https=)
ES (1) ES433759A1 (https=)
FI (1) FI54053C (https=)
FR (1) FR2257305B1 (https=)
GB (1) GB1498261A (https=)
HK (1) HK56380A (https=)
HU (1) HU173920B (https=)
IE (1) IE40794B1 (https=)
IL (1) IL46426A (https=)
MY (1) MY8100204A (https=)
NL (1) NL166622C (https=)
NO (1) NO143128C (https=)
PH (1) PH14458A (https=)
PL (1) PL93689B1 (https=)
SE (1) SE427238B (https=)
SU (1) SU616997A3 (https=)
YU (1) YU41289B (https=)
ZA (1) ZA75259B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
ES2525518T3 (es) * 2005-11-01 2014-12-26 Novartis Vaccines And Diagnostics Gmbh Vacunas virales derivadas de células con niveles reducidos de ADN celular residual
EP2192917B1 (en) * 2007-08-28 2014-01-29 Baxter International Inc. Method for producing viral vaccines
JP6373376B2 (ja) 2013-11-15 2018-08-15 ノバルティス アーゲー 残留細胞培養不純物の除去

Also Published As

Publication number Publication date
FI54053C (fi) 1978-10-10
DK1475A (https=) 1975-09-01
CS191254B2 (en) 1979-06-29
AU7730575A (en) 1976-07-15
IE40794L (en) 1975-07-14
JPS58407B2 (ja) 1983-01-06
SU616997A3 (ru) 1978-07-25
AT345449B (de) 1978-09-11
FI54053B (fi) 1978-06-30
YU5875A (en) 1984-04-30
CH589453A5 (https=) 1977-07-15
NL166622C (nl) 1981-09-15
NO750031L (https=) 1975-08-11
NO143128B (no) 1980-09-15
NL7500301A (nl) 1975-07-16
ES433759A1 (es) 1977-02-16
DD116239A5 (https=) 1975-11-12
DE2500785B2 (de) 1980-01-03
GB1498261A (en) 1978-01-18
BE824372A (fr) 1975-07-14
JPS50100224A (https=) 1975-08-08
ATA21475A (de) 1978-01-15
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
FR2257305A1 (https=) 1975-08-08
HK56380A (en) 1980-10-16
JPS6035326B2 (ja) 1985-08-14
PL93689B1 (https=) 1977-06-30
JPS56127319A (en) 1981-10-06
DE2500785A1 (de) 1975-07-31
DK140003C (https=) 1979-10-29
AU500250B2 (en) 1979-05-17
DE2500785C3 (https=) 1980-09-11
FI750014A7 (https=) 1975-07-15
IL46426A0 (en) 1975-04-25
MY8100204A (en) 1981-12-31
HU173920B (hu) 1979-09-28
IL46426A (en) 1978-01-31
DK140003B (da) 1979-06-05
PH14458A (en) 1981-07-29
YU41289B (en) 1987-02-28
IE40794B1 (en) 1979-08-15
NL166622B (nl) 1981-04-15
FR2257305B1 (https=) 1982-03-19
SE427238B (sv) 1983-03-21
SE7500130L (https=) 1975-07-15

Similar Documents

Publication Publication Date Title
US3962421A (en) Method for the disruption of lipid-containing viruses
US4064232A (en) Process for isolating the immunogenic components of influenza viruses
Leist et al. Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells.
CA1049406A (en) Isolation of hemagglutinin and neuraminidase from influenza virus
US4140762A (en) Influenza sub-unit vaccine
US4029763A (en) Influenza vaccine containing purified neuraminidase antigen and method of using the same
AU2025205386A1 (en) Feline calicivirus vaccine
McLaren et al. Defective interfering particles from poliovirus vaccine and vaccine reference strains
AU2025279721A1 (en) Multivalent feline vaccine
JPH10508485A (ja) 弱毒化イヌパルボウイルス
Hooks et al. Isolation of a new simian foamy virus from a spider monkey brain culture
DE2829089A1 (de) Subunit-vakzine
US4946676A (en) Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
Kilbourne et al. Hemagglutinin mutants of swine influenza virus differing in replication characteristics in their natural host
EP3706789A1 (en) Feline calicivirus vaccine
CN116144612A (zh) 重组乙型流感病毒及其制备方法与应用
KR790001144B1 (ko) 인플루엔자 백신의 제조방법
Iwasaki et al. Communications: Effect of Lymphocytosis-Promoting Factor (LPF) on the Appearance of Antibodies in Mice Infected with Influenza Virus
US11229699B2 (en) Feline calicivirus vaccine
Polezhaev et al. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus
CA2112225C (en) Attenuated revertant serotype 1 marek's disease vaccine
AU2019346177A1 (en) Inactivated whole-virus influenza vaccine and method for preparing same
Lomniczi Properties of non-neurovirulent plaque-forming mutants of Newcastle disease virus
CA1073355A (en) Influenza vaccine containing purified neuraminidase antigen and method of using the same
Masurel et al. Vaccination and protection experiments in mice with the human A-1957 and A-1968 strains, and the Equi-2 strain of influenza virus